Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.
The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2018-05-09 | Committee | Ordered to be Reported by Voice Vote. | House committee actions |
| 2018-05-09 | Committee | Committee Consideration and Mark-up Session Held. | House committee actions |
| 2018-04-25 | Committee | Forwarded by Subcommittee to Full Committee by Voice Vote . | House committee actions |
| 2018-04-25 | Committee | Subcommittee Consideration and Mark-up Session Held. | House committee actions |
| 2018-04-06 | Committee | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. | House committee actions |
| 2018-03-09 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2018-03-07 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2018-03-07 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2018-03-07 | IntroReferral | Introduced in House | Library of Congress |